BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

UCB Group 

Allée de la Recherche, 60

Brussels    1070  Belgium
Phone: (32-2) 559-99-99 Fax: (32-2) 559-99-00


SEARCH JOBS










 Company News
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures 9/2/2014 11:37:51 AM
UCB Group (UCBJF.PK) And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol) 7/3/2014 6:38:35 AM
Beryllium Strengthens Collaboration With Key Partner, UCB Group (UCBJF.PK) 5/20/2014 10:17:06 AM
Biopharma Learns From Marvel, UCB Group (UCBJF.PK) And Massachusetts Institute of Technology (MIT) Begin Real Life Search For "X-Men" 4/30/2014 7:13:29 AM
UCB Group (UCBJF.PK) Not For Sale As Billionaire Shareholder Awaits Reward 12/2/2013 8:06:35 AM
Evotec AG (EVTG.F) Achieves First Milestones in Multi-Target Deal With UCB Group (UCBJF.PK) 10/28/2013 9:50:59 AM
UCB Group (UCBJF.PK)'s Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults With Active Ankylosing Spondylitis 10/18/2013 8:56:49 AM
Immunomedics, Inc. (IMMU) Reports That UCB Group (UCBJF.PK) Announces New Results From Phase 2B Open-Label Extension Study Evaluating the Long-Term Effects of Epratuzumab in SLE 6/13/2013 8:49:32 AM
UCB Group (UCBJF.PK) Chooses Emerson Automation and Operations Management Technologies for One of Europe’s Largest Biotech Plants 1/9/2013 10:12:20 AM
UCB Group (UCBJF.PK) Announces Data on Cimzia® (certolizumab pegol) for Patients With Moderate to Severe Rheumatoid Arthritis at American College of Rheumatology 2012 Congress 11/13/2012 10:55:38 AM
12345678910...